ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979